Winnebago Q1 Earnings Beat Estimates, Raises FY26 Outlook
Winnebago (WGO) swings to Q1 profit with 12% revenue growth, beats analyst estimates, and raises fiscal 2026 guidance on strong RV demand and improved margins.
NOTRELOAD AI
Spero Therapeutics Secures $25M Milestone Payment from GSK Partnership
Spero Therapeutics announces $25 million milestone payment following GSK's FDA resubmission for tebipenem HBr antibiotic treatment for urinary tract infections.
Galectin Therapeutics Faces Regulatory Hurdles, Needs More Cash to Stay Afloat
Galectin Therapeutics fails to secure FDA meeting, requires additional $10M credit line from chairman to continue operations through 2027 amid ongoing development struggles.
BioMarin to Acquire Amicus Therapeutics in $4.8 Billion Deal
BioMarin announces $4.8 billion acquisition of Amicus Therapeutics, adding rare disease treatments Galafold and Pombiliti to its portfolio with expected close in Q2 2026.
Wedbush Downgrades Lyft Over Autonomous Vehicle Risks
Wedbush downgraded Lyft to Underperform, warning that autonomous vehicles could significantly hurt the company’s long-term value and U.S.-focused business.
Citigroup Predicts Major Crypto Rally: Bitcoin to Hit $143K, Ethereum $4.3K
Citigroup forecasts bitcoin reaching $143,000 and ethereum $4,304 within 12 months, citing regulatory improvements and growing adoption despite recent market volatility.